IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Cell Therapy in Severe Chronic Ischemic Heart Disease (MiHeart)
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2012 by Dr. Luís Henrique W. Gowdak, Ministry of Health, Brazil.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
Ministry of Health, Brazil
Information provided by (Responsible Party):
Dr. Luís Henrique W. Gowdak, Ministry of Health, Brazil
ClinicalTrials.gov Identifier:
NCT01727063
First received: November 12, 2012
Last updated: NA
Last verified: November 2012
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with advanced coronary artery disease usually undergo incomplete myocardial revascularization due to the extension and diffuseness of the disease, with very poor distal arterial beds unsuitable for direct revascularization.
This study was designed to test the hypothesis that direct, intramyocardial injection of autologous bone marrow cells may further improve myocardial perfusion in patients undergoing incomplete bypass surgery.
| Condition | Intervention | Phase |
|---|---|---|
| Chronic Ischemic Heart Disease Coronary Artery Disease Angina Pectoris | Procedure: Cell Therapy | Phase 2 Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator) Primary Purpose: Treatment |
| Official Title: | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy of Intramyocardial Injection of Autologous Bone-Marrow Cells in Patients With Severe, Chronic Ischemic Heart Disease Undergoing Coronary Bypass Surgery |
Resource links provided by NLM:
Further study details as provided by Dr. Luís Henrique W. Gowdak, Ministry of Health, Brazil:
Primary Outcome Measures:
- Increase in myocardial perfusion [ Time Frame: 1, 6 and 12 months ]Patients will undergo myocardial perfusion assessment by MRI during pharmacological stress with adenosine or dipyridamole. Alternatively, cardiac scintigraphy can be used in patients with contra-indications to MRI.
Secondary Outcome Measures:
- Improvement in LV function [ Time Frame: 1, 6 and 12 months ]LV function (global and regional) will be assessed by MRI.
Other Outcome Measures:
- Improvement in angina functional class [ Time Frame: 1, 6 and 12 months ]Angina functional class will be determined using the Canadian Cardiovascular Society classification.
| Estimated Enrollment: | 200 |
| Study Start Date: | January 2006 |
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Cell Therapy
Intramyocardial injection of autologous bone marrow-derived cells
|
Procedure: Cell Therapy
Intramyocardial injection of autologous bone marrow-derived cells
|
|
No Intervention: Placebo
Saline injection
|
Detailed Description:
All eligible patients will undergo coronary artery bypass grafting (CABG) and, in previously identified areas of viable, ischemic myocardium unsuitable for direct revascularization, be randomized to either placebo (saline) or intramyocardial injection of bone marrow-derived cells (BMC) during surgery.
During follow-up, myocardial perfusion assessment will be performed to determine the improvement in treated areas compared to non-treated segments.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- symptoms of angina or angina equivalent
- documented coronary artery disease (invasive angiography)
- documented myocardial ischemia (stress echo, cardiac scintigraphy, or MRI)
- unsuitable for complete myocardial revascularization (PCI or CABG) OR even if a complete procedure in feasible, it is anticipated that myocardial perfusion may not be restored due to poor distal beds
Exclusion Criteria:
- severe LV dysfunction (EF < 25% on echo)
- short life expectacy (below < 1 year)
- diagnosis of cancer in the past 5 years
- diagnosis of hematological diseases
- diagnosis of severe heart disease of other etiologies including valvular heart disease, Chagas' disease, etc)
- diagnosis of acute coronary syndrome in the past 3 months
- diagnosis of chronic kidney disease stage V requiring chronic dialysis
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01727063
Please refer to this study by its ClinicalTrials.gov identifier: NCT01727063
Contacts
| Contact: Meyrielli A Vieira | +55-11-2661-5000 ext 5377 | meyri.vieira@incor.usp.br | |
| Contact: Luis Henrique Gowdak, MD, PhD | +55-11-2661-5000 ext 5929 | luis.gowdak@incor.usp.br |
Locations
| Brazil | |
| Heart Institute | Recruiting |
| Sao Paulo, SP, Brazil, 05403-000 | |
| Principal Investigator: Luis Henrique W Gowdak, MD, PhD | |
Sponsors and Collaborators
Ministry of Health, Brazil
Investigators
| Study Director: | Jose Eduardo Krieger, MD, PhD | Heart Institute |
| Study Chair: | Carlos Eduardo Rochitte, MD, PhD | Heart Institute |
More Information
Publications:
| Responsible Party: | Dr. Luís Henrique W. Gowdak, Clinical Coordinator, Ministry of Health, Brazil |
| ClinicalTrials.gov Identifier: | NCT01727063 History of Changes |
| Other Study ID Numbers: |
EMRTCC-ISQ2 |
| Study First Received: | November 12, 2012 |
| Last Updated: | November 12, 2012 |
Keywords provided by Dr. Luís Henrique W. Gowdak, Ministry of Health, Brazil:
|
Chronic ischemic heart disease Coronary artery disease Angina pectoris Myocardial ischemia Cardiac surgery |
Additional relevant MeSH terms:
|
Ischemia Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases Angina Pectoris Pathologic Processes Cardiovascular Diseases |
Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Chest Pain Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on August 18, 2017